首頁 > 市場調查報告書 > 醫療設備

過敏診斷和治療市場規模、佔有率和成長分析（按類型、過敏原類型、檢測類型和地區分類）—產業預測，2026-2033年

市場調查報告書

商品編碼

1895891

過敏診斷和治療市場規模、佔有率和成長分析（按類型、過敏原類型、檢測類型和地區分類）—產業預測，2026-2033年

Allergy Diagnostics and Therapeutics Market Size, Share, and Growth Analysis, By Type (Diagnostics, Therapeutics), By Allergen Type (Food, Inhaled), By Test Type, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月15日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，過敏診斷和治療市場規模將達到 333.9 億美元，到 2025 年將成長至 363.3 億美元，到 2033 年將成長至 713.3 億美元，在預測期（2026-2033 年）內複合年成長率為 8.8%。

受多種因素影響，全球過敏診斷和治療市場預計將呈現強勁成長。日益嚴重的環境污染和醫療保健服務的可近性提高是關鍵促進因素。過敏性疾病的增加帶來了巨大的經濟壓力，促使各機構增加對過敏診斷的投資。不健康的飲食習慣和日益嚴重的污染等生活方式改變也進一步推動了市場需求。食物過敏的顯著增加（主要由於缺乏飲食意識）預計將推動對診斷解決方案的需求。此外，行動醫療技術的融合以及對先進治療策略的持續研究也促進了市場擴張。包括創新血液檢測在內的技術進步為該領域的成長提供了巨大的機會。

過敏診斷與治療市場促進因素

與農村地區相比，都市區過敏性疾病的發生率顯著更高，這主要是由於城市環境中環境污染物的暴露量更高。這一成長趨勢凸顯了開發有效過敏診斷和治療方法的緊迫性。隨著都市化的加快，對創新解決方案的需求預計將會增加，以應對和管理這些過敏症狀，從而推動市場發展。此外，人們對過敏對生活品質影響的認知不斷提高，也進一步推動了對更佳診斷工具和治療方法的追求，進而促進了過敏診斷和治療行業的成長。

過敏診斷和治療市場的限制因素

過敏診斷和治療市場面臨許多挑戰，這些挑戰可能會阻礙其成長。其中一個關鍵因素是過敏診斷設備成本的不斷上升。這種經濟負擔可能會阻礙醫療機構採用最新技術。此外，過敏專家的短缺可能會加劇這種情況，導致缺乏能夠解讀檢測結果並有效管理患者照護的專業人員。這些障礙凸顯了進行市場調查的必要性，該研究需要全面分析近期發展、法規、競爭格局以及新興領域的機會。這些資訊對於希望了解市場複雜性並推動未來成長舉措的相關人員至關重要。

過敏診斷和治療市場的發展趨勢

受全球過敏性疾病盛行率不斷上升的推動，過敏診斷和治療市場正經歷強勁成長。生活方式的改變、環境污染和飲食習慣的變化導致過敏症發病率上升，因此對創新診斷工具和有效治療方法的需求日益成長。個人化醫療和免疫療法等技術的進步也提升了過敏症的管理能力。此外，人們對過敏原及其健康影響的認知和教育的不斷提高也推動了市場擴張，使該行業成為醫療保健領域的重要組成部分。

Thermo Fisher Scientific Inc.（US）
Siemens Healthineers（Germany）
Danaher（US）
Omega Diagnostics Group PLC（UK）
bioMerieux SA（France）
Romer Labs Division Holding（Austria）
EUROIMMUN Medizinische Labordiagnostika AG（Germany）
HollisterStier Allergy（US）
NEOGEN Corporation（US）
Eurofins Scientific（Luxembourg）
Minaris Medical America Inc.（US）
HOB Biotech Group Corp. Ltd.（China）
HYCOR Biomedical（US）
R-Biopharm AG（Germany）
AESKU.GROUP GmbH（Germany）
ACON Laboratories Inc.（US）
Lincoln Diagnostics Inc.（US）
Astra Biotech GmbH（Germany）
ERBA Group（UK）

結論與建議

簡介目錄

Product Code: SQMIG35H2183

Allergy Diagnostics and Therapeutics Market size was valued at USD 33.39 Billion in 2024 and is poised to grow from USD 36.33 Billion in 2025 to USD 71.33 Billion by 2033, growing at a CAGR of 8.8% during the forecast period (2026-2033).

The global allergy diagnostics and therapeutics market is poised for robust growth due to a myriad of influencing factors. Rising environmental pollution levels and enhanced healthcare insurance accessibility are key drivers. The increasing prevalence of allergic diseases is exerting significant economic pressure, prompting organizations to invest more in allergy diagnostics. Shifting lifestyle patterns, characterized by unhealthy dietary choices and heightened pollution, further accelerate market demand. A notable surge in food allergies, largely stemming from a lack of dietary awareness, is expected to escalate the need for diagnostic solutions. Additionally, the integration of mobile health technologies and ongoing research into advanced treatment strategies are catalyzing market expansion. Technological advancements, including innovative blood tests, present considerable opportunities for growth in this sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Allergy Diagnostics and Therapeutics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Allergy Diagnostics and Therapeutics Market Segments Analysis

Global Allergy Diagnostics and Therapeutics Market is segmented by type, allergen type, test type and region. Based on type, the market is segmented into diagnostics and therapeutics. Based on allergen type, the market is segmented into food, inhaled, drug and other allergens. Based on test type, the market is segmented into in vivo test and in vitro test. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Allergy Diagnostics and Therapeutics Market

The growing prevalence of allergic disorders is significantly higher in urban populations than in rural counterparts, largely attributed to the heightened exposure to environmental pollutants found in city settings. This rising trend underscores a pressing need for effective allergy diagnostics and therapeutics. As urbanization continues to expand, the demand for innovative solutions to address and manage these allergic conditions is likely to increase, driving advancements in the market. Additionally, the awareness surrounding the impact of allergies on quality of life further fuels the pursuit of improved diagnostic tools and treatment options, fostering growth within the Allergy Diagnostics and Therapeutics sector.

Restraints in the Allergy Diagnostics and Therapeutics Market

The Allergy Diagnostics and Therapeutics market faces significant challenges that could impede its growth, primarily due to the escalating costs associated with allergy diagnostic instruments. This financial burden may deter healthcare providers from adopting the latest technologies. Additionally, a lack of allergists may exacerbate the situation, creating a shortage of skilled professionals to interpret test results and manage patient care effectively. Such obstacles underscore the necessity for comprehensive market analysis encompassing recent developments, regulations, competitive landscape, and opportunities in emerging areas. This information is vital for stakeholders aiming to navigate the complexities of the market and drive future growth initiatives.

Market Trends of the Allergy Diagnostics and Therapeutics Market

The Allergy Diagnostics and Therapeutics market is experiencing robust growth, driven by the rising prevalence of allergic diseases globally. As lifestyle changes, environmental pollution, and shifts in dietary patterns contribute to the surge in allergies, there is an escalating demand for innovative diagnostic tools and effective treatment options. Advancements in technology, such as the development of personalized medicine and immunotherapy, are also enhancing the capabilities of allergy management. Additionally, increased awareness and education surrounding allergens and their impact on health further fuel the market's expansion, positioning it as a critical sector in the healthcare landscape.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Study Analysis

Global Allergy Diagnostics and Therapeutics Market Size by Type & CAGR (2026-2033)

Market Overview
Diagnostics
- Instruments
- Consumables
- Services
Therapeutics
- Antihistamines
- Decongestants
- Corticosteroids
- Mast Cell Stabilizers
- Leukotriene Inhibitors
- Nasal Anti-Cholinergic
- Immuno-Modulators
- Epinephrine
- Immunotherapy

Global Allergy Diagnostics and Therapeutics Market Size by Allergen Type & CAGR (2026-2033)

Market Overview
Food
- Dairy Products
- Poultry Product
- Tree Nuts
- Peanuts
- Shellfish
- Wheat
- Soys
- Other Food Allergens
Inhaled
Drug
Other Allergens

Global Allergy Diagnostics and Therapeutics Market Size by Test Type & CAGR (2026-2033)

Market Overview
In Vivo Test
- Skin Prick Test
- Intradermal Test
- Patch Test
In Vitro Test

Global Allergy Diagnostics and Therapeutics Market Size & CAGR (2026-2033)

North America (Type, Allergen Type, Test Type)
- US
- Canada
Europe (Type, Allergen Type, Test Type)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Type, Allergen Type, Test Type)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Type, Allergen Type, Test Type)
- Brazil
- Rest of Latin America
Middle East & Africa (Type, Allergen Type, Test Type)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Thermo Fisher Scientific Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Omega Diagnostics Group PLC (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
bioMerieux SA (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Romer Labs Division Holding (Austria)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
EUROIMMUN Medizinische Labordiagnostika AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
HollisterStier Allergy (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NEOGEN Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eurofins Scientific (Luxembourg)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Minaris Medical America Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
HOB Biotech Group Corp. Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
HYCOR Biomedical (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
R-Biopharm AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AESKU.GROUP GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ACON Laboratories Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lincoln Diagnostics Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Astra Biotech GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ERBA Group (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments